← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 12, 2018Last known activity
Oct 31, 2024
Timeline
2010s
- Jun 1, 2017
Osivax S.A.S— Founded
Drugs by trial phase (3 distinct, 8 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06582277OfficialPhase 2Oct 31, 2024
- NCT06582277Lead sponsorPhase 2Oct 31, 2024
- NCT06128382Lead sponsorPhase 1Jan 31, 2024
- NCT05734040Lead sponsorPhase 2May 10, 2023
- NCT05569239Lead sponsorPhase 2Apr 1, 2023
- NCT05284799Lead sponsorPhase 2May 9, 2022
- NCT05060887Lead sponsorPhase 2Nov 15, 2021
- NCT04192500Lead sponsorPhase 2Dec 31, 2019
- NCT03594890Lead sponsorPhase 1Jun 12, 2018
Details
- Founded
- Lyon, FR Jun 1, 2017
- Last known activity
- Oct 31, 2024